Literature DB >> 2646052

Long-term outcome of Schönlein-Henoch nephritis in the adult.

G B Fogazzi1, S Pasquali, M Moriggi, S Casanova, I Damilano, M J Mihatsch, P Zucchelli, C Ponticelli.   

Abstract

Sixteen adult patients with Schönlein-Henoch nephritis, selected by strict inclusion criteria, were studied retrospectively. At the time of discovery of the nephropathy, 11 patients had normal plasma creatinine and 5 other patients had renal insufficiency. All patients had renal biopsies, which were studied by both light and immunofluorescence microscopy. After a mean follow-up of 90.5 +/- 59.1 months (range 16-261), 3 patients were in chronic dialysis (18.7%), 8 other patients had renal function deterioration (50%), with creatinine clearance ranging from 31 to 60 ml/min. Four other patients had mild urinary abnormalities with normal plasma creatinine (25%) and only 1 patient was in complete clinical remission (6%). No clinical features at onset were predictive for the clinical outcome of the disease, while in the biopsies the percentage of crescents was higher in patients who developed renal insufficiency. High IgA serum levels were correlated (p = 0.0242) with a favorable course. It is concluded that Schönlein-Henoch nephritis of the adult carries a high long-term risk of renal dysfunction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2646052

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  14 in total

Review 1.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

2.  IgA vasculitis (formerly Henoch-Schönlein purpura) in an adult with systemic lupus erythematosus.

Authors:  Vera Bernardino; Pedro Mendes-Bastos; Ana Rodrigues; Nuno Riso
Journal:  BMJ Case Rep       Date:  2015-09-09

3.  Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.

Authors:  Meral Torun Bayram; Cihan Heybeli; Gizem Yıldız; Alper Soylu; Ali Celik; Sülen Sarioglu; Salih Kavukçu
Journal:  Int Urol Nephrol       Date:  2021-11-30       Impact factor: 2.266

4.  Comparison between adults and children with Henoch-Schönlein purpura nephritis.

Authors:  Shan Lu; Dong Liu; Jing Xiao; Wenming Yuan; Xiaoyang Wang; Xiaoxue Zhang; Jin Zhang; Zhangsuo Liu; Zhanzheng Zhao
Journal:  Pediatr Nephrol       Date:  2014-12-07       Impact factor: 3.714

Review 5.  Henoch-Schönlein purpura nephritis in children.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

6.  Spontaneous Bacterial Peritonitis and Henoch-Schönlein Purpura in a Patient with Liver Cirrhosis.

Authors:  Neil Gupta; Joyce Kim; Basile Njei
Journal:  Case Rep Med       Date:  2015-05-07

7.  Successful treatment of Henoch-Schonlein purpura nephritis with plasma exchange in an adult male.

Authors:  Kunal Chaudhary; Ji-Young Shin; Georges Saab; Alan M Luger
Journal:  NDT Plus       Date:  2008-07-25

8.  Successful prednisolone therapy in elderly patients with severe forms of henoch-schönlein purpura nephritis.

Authors:  Saiko Kato-Okada; Hiromichi Suzuki; Tsutomu Inoue; Tomohiro Kikuta; Hirokazu Okada
Journal:  Jpn Clin Med       Date:  2015-04-06

9.  Henoch-Schönlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center.

Authors:  Vanesa Calvo-Río; Javier Loricera; Cristina Mata; Luis Martín; Francisco Ortiz-Sanjuán; Lino Alvarez; M Carmen González-Vela; Domingo González-Lamuño; Javier Rueda-Gotor; Héctor Fernández-Llaca; Marcos A González-López; Susana Armesto; Enriqueta Peiró; Manuel Arias; Miguel A González-Gay; Ricardo Blanco
Journal:  Medicine (Baltimore)       Date:  2014-03       Impact factor: 1.889

10.  Validation of the absolute renal risk of dialysis/death in adults with IgA nephropathy secondary to Henoch-Schönlein purpura: a monocentric cohort study.

Authors:  Hesham Mohey; Blandine Laurent; Christophe Mariat; Francois Berthoux
Journal:  BMC Nephrol       Date:  2013-08-01       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.